Lidl issues urgent ‘do not eat' warning over popular product amid allergy fear
Lidl GB has told consumers who bought the Red Hen 4 Tempura Chicken Steaks 380g to check whether they are part of the affected batch.
The product is being recalled because milk has not been boldened in the ingredients section - with the supermarket warning this could pose a health risk to people intolerant to milk.
'Lidl GB is recalling the above-mentioned product due to milk not being in bold within the back of pack ingredients,' the supermarket said in its product recall notice.
'This may be a possible health risk for anyone with an allergy to milk.
'If you have bought the above product and have an allergy to milk we advise you not to eat it.
'Customers are asked to return this product to the nearest store where a full refund will be given.'
The Food Standards Agency (FSA) said the product 'contains milk making it a possible health risk for anyone with an allergy or intolerance to milk or milk constituents'.
'Lidl is recalling the above product from customers and has been advised to contact the relevant allergy support organisations, which will tell their members about the recall,' the FSA added.
'The company has also issued a point-of-sale notice to its customers. These notices explain to customers why the product is being recalled and tell them what to do if they have bought the product.'
The recall only applies to the packs with the following 'best before' dates:
11/12/2026
16/12/2026
22/12/2026
30/12/2026
16/01/2027
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
37 minutes ago
- The Guardian
My friends had to subsidise the cost of running my vital oxygen therapy
I am dependent on long-term oxygen therapy after a double lung transplant. I'm entitled to reimbursement of the excess electricity used by the oxygen concentrator and have received quarterly payments of about £48 from Vivisol, which administers rebates on behalf of the NHS. However, I was forced to stay with friends and family for a year after my house was flooded, and I spent a further two months convalescing at my daughter's house after a heart operation. I received no rebates during that time, and Vivisol told me l would not be reimbursed while I was not living at home, which means my hosts had to subsidise my treatment. SS, East Sussex The rebate scheme is intended to protect eligible patients who rely on an oxygen concentrator from spiralling energy costs. I see that Vivisol's website states, in passing, that patients are eligible for the cost of using the machine at their main address. This strikes me as insufficiently clear, as well as potentially unfair. It's a no-brainer that those with such serious health issues might have to relocate, as you did, for convalescence, for respite care or building work. It seems unreasonable to me to expect friends and family to foot what can be a considerable bill for treatment and, since concentrators record electricity consumption on an integrated meter unconnected to the household meter, it is straightforward to be able to monitor the costs involved. I first approached NHS England to ask if this restriction was NHS policy and whether there were exemptions for cases such as yours. It referred me to the NHS Sussex Integrated Care Board, which explained that patients can nominate a temporary address as their main residence via their service provider in circumstances such as yours. In the meantime, Vivisol responded to my contact by agreeing to reinstate and backdate your rebates to cover the period while you were away. A spokesperson said: 'All communication does highlight that the eligibility only applies at the patient's main address. As a result of your email, we will review to identify if that can be made clearer.' We welcome letters but cannot answer individually. Email us at or write to Consumer Champions, Money, the Guardian, 90 York Way, London N1 9GU. Please include a daytime phone number. Submission and publication of all letters is subject to our terms and conditions.
Telegraph
37 minutes ago
- Telegraph
Free STI vaccines offered at health clinics
The Labour Government is calling on those who are sexually active and eligible to take up a free STI vaccine on the NHS. The world's first gonorrhoea vaccination programme is being rolled out by the NHS and local authorities and is now available at sexual health clinics in England for people at highest risk of infection. From Monday, clinics will be able to offer the free vaccine to those at highest risk of the sexually transmitted infection (STI), including gay and bisexual men who have a recent history of multiple sexual partners and a bacterial STI in the previous 12 months. Ashley Dalton, Minister for Public Health and Prevention, said: 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.' The vaccination programme comes at a critical time, with diagnoses of gonorrhoea reaching their highest levels since records began. In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. The Government says this vaccine will protect thousands of people and save the NHS more than £7.9 million over the next decade. It will also help combat increasing levels of antibiotic-resistant strains of the disease. The vaccine that can now be offered to 'high-risk individuals' at local sexual health clinics is the existing vaccine for meningococcal disease (4CMenB) that also helps protect against gonorrhoea. Eligible patients attending clinics for the gonorrhoea vaccine will also be offered mpox, hepatitis A and B and human papillomavirus (HPV) vaccinations, which the Government says will provide comprehensive protection against an array of diseases. Dr Amanda Doyle, NHS national director for primary care and community services, said: 'The roll out of the NHS' world-first routine vaccination for gonorrhoea from this month is a real step-forward for sexual health and I know health service staff, alongside local authority colleagues, have been working hard to hit the ground running. 'This vaccine is already used to protect against Men B and is proven to be effective against gonorrhoea, preventing the spread of infection and reducing the rising rates of antibiotic-resistant strains. 'That is why it is so important that everyone eligible takes up the offer through sexual health services alongside existing jabs for mpox, Hep A & B, and HPV, helping ensure we keep each other safe.' Gonorrhoea is the second most common STI in the UK, and officials are becoming increasingly concerned that it could become 'untreatable' following a rise in an antibiotic-resistant strain from abroad. The programme will primarily target gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI, who are at an increased risk of becoming infected. The UK Health Security Agency (UKHSA) data show there was a 9.4 per cent increase in gonorrhoea diagnoses among this group in 2023, with cases rising from 37,095 to 40,586. ENDS
The Independent
an hour ago
- The Independent
World-first vaccine rolled out across England amid record levels of infection
England has launched a world-first gonorrhoea vaccination programme, aimed at curbing soaring infection rates and tackling the growing threat of antibiotic-resistant strains. The initiative comes after cases of the sexually transmitted infection (STI) in England reached a record 85,000 in 2023, the highest since records began in 1918. Available free of charge from Monday at sexual health clinics, the jab is being offered to those at highest risk. This includes gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine, an existing jab known as 4CMenB, is currently used to protect against meningococcal B disease, which can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. Officials anticipate the programme will save the NHS £7.9 million over the next decade. The programme could prevent up to 100,000 cases of gonorrhoea, according to doctors. The STI disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels,' Ashley Dalton, the minister for public health and prevention, said. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'
